- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02564653
Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System
May 29, 2020 updated by: NYU Langone Health
Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System:a Rural Model
Vietnam has a smoking prevalence that is the second highest among South East Asian countries (SEACs).
With a population of approximately 90 million, Vietnam also has the second largest total number of adult smokers (over 16 million) in SEA.
According to the World Health Organization (WHO), most reductions in mortality from tobacco use in the near future will be achieved through helping current users quit.
Tobacco use treatment, as defined by the U.S. Preventive Health Service Guideline (Guideline) on Treating Tobacco use and Dependence, is evidence-based and highly cost-effective.
Yet, in the U.S. and globally, adoption of recommended care is suboptimal.
The objective of this proposal is to fill the current research-to-practice gap by conducting a randomized controlled trial that compares the effectiveness and cost effectiveness of two practical and highly replicable strategies for implementing evidence-based guidelines for the treatment of tobacco use in public health clinics in Vietnam.
The proposed implementation strategies draw on evidence-based approaches, and the WHO's recently released guidelines for implementing Article 14 of the Framework Convention on Tobacco Control (FCTC).
The FCTC is an evidence-based treaty that was developed by the WHO in response to the globalization of the tobacco epidemic.
Vietnam ratified the FCTC in 2004; however, they have not taken steps to implement Article 14 which specifies the need to integrate best practices for treating tobacco use and dependence into routine preventive care.
The proposed implementation strategies also build on the growing literature that supports the effectiveness of integrating community health workers as members of the health care team to improve access to preventive services.
Study Overview
Status
Completed
Conditions
Detailed Description
The long-term goal of the project is to develop a generalizable model for implementing evidence-based tobacco use treatment within existing health systems locally and globally.
The objective of this proposal is to fill the current research-to-practice gap by conducting a randomized controlled trial that compares the effectiveness and cost of two practical and highly replicable strategies for implementing evidence-based guidelines for the treatment of tobacco use in public health clinics and community based settings in Vietnam.
The proposed implementation strategies draw on evidence-based approaches and the WHO's recently released guidelines for implementing Article 14 of the Framework Convention on Tobacco Control (FCTC).
The FCTC is an evidence-based treaty that was developed by the WHO in response to the globalization of the tobacco epidemic Article 14specifies the need to integrate clinical best practices for treating tobacco use and dependence into routine preventive care.
The proposed implementation strategies also build on the growing literature that supports the effectiveness of integrating community health workers as members of the health care team to improve access to preventive services.
Study Type
Interventional
Enrollment (Actual)
4733
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- NYU Langone Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient eligibility:
- Current patients at community health center for routine visit
- 18 years or older
- Current or regular smoker (>1 cigarette in past 7 days)
- Willingness to complete survey
- 18 years or older
- Willingness to complete survey or interview
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Technical Assistance, training,clinical reminders
provider adherence to tobacco use treatment guidelines
|
Technical Assistance, training and clinical reminders (TTC)
|
|
Other: TTC + help of community health workers
We will assess this secondary aim by comparing smoking cessation outcomes among smokers who receive brief provider counseling alone only vs. smokers who receive provider counseling + community health worker counseling.
The purpose of this assessment is to specifically analyze the impact of the community health worker counseling component of the intervention using a quasiexperimental design that leverages the larger RCT.
|
TTC+ referral to a VHW for additional counseling and follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to tobacco use treatment guidelines and costs
Time Frame: Up to 12 months
|
patient exit interviews
|
Up to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking abstinence
Time Frame: Up to 12 months
|
Surveys will be conducted in person and smoking abstinence will be validated using carbon monoxide (CO) monitoring
|
Up to 12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Barriers and facilitators for tobacco use treatment
Time Frame: Up to 12 months
|
practice environment checklist to inventory current policies, work flow, systems (e.g.
chart systems) and staff roles and responsibilities in general and specifically related to tobacco use treatment
|
Up to 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Donna Shelley, MD, MPH, NYU School of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- VanDevanter N, Vu M, Nguyen A, Nguyen T, Van Minh H, Nguyen NT, Shelley DR. A qualitative assessment of factors influencing implementation and sustainability of evidence-based tobacco use treatment in Vietnam health centers. Implement Sci. 2020 Sep 9;15(1):73. doi: 10.1186/s13012-020-01035-6.
- VanDevanter N, Kumar P, Nguyen N, Nguyen L, Nguyen T, Stillman F, Weiner B, Shelley D. Application of the Consolidated Framework for Implementation Research to assess factors that may influence implementation of tobacco use treatment guidelines in the Viet Nam public health care delivery system. Implement Sci. 2017 Feb 28;12(1):27. doi: 10.1186/s13012-017-0558-z.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2015
Primary Completion (Actual)
August 1, 2019
Study Completion (Actual)
August 1, 2019
Study Registration Dates
First Submitted
September 2, 2015
First Submitted That Met QC Criteria
September 30, 2015
First Posted (Estimate)
October 1, 2015
Study Record Updates
Last Update Posted (Actual)
June 1, 2020
Last Update Submitted That Met QC Criteria
May 29, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 14-01422
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tobacco Use Cessation
-
University of Mississippi Medical CenterNot yet recruitingTobacco Cessation
-
Duke UniversityCompletedSmokeless Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Vanderbilt University Medical CenterCompletedTobacco Use | Tobacco Use Cessation
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
Loma Linda UniversityUniversity of California, San Francisco; Riverside University Health System...RecruitingTobacco Use | Tobacco Use Cessation | Tobacco Use in ChildbirthUnited States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Cessation | Tobacco Use | Tobacco Use Cessation | Tobacco Dependence | Tobacco AbstinenceUnited States
-
HealthPartners InstituteMinnesota Partnership for Action Against TobaccoCompleted
-
The University of Hong KongQueen Elizabeth Hospital, Hong Kong; Food and Health Bureau, Hong Kong; Queen... and other collaboratorsCompletedSmoking Cessation | Tobacco Use CessationHong Kong
Clinical Trials on Technical Assistance, training and clinical reminders
-
NYU Langone HealthWithdrawnTobacco Use CessationVietnam
-
Oregon Research InstituteStanford University; University of Texas at Austin; Trinity University, TexasCompletedEating DisorderUnited States
-
Duke UniversityUniversity of Pittsburgh; University of South Carolina; Whole Child InternationalCompletedMental Health Wellness 1 | Health Behavior | Child RearingEl Salvador
-
Boise State UniversityNational Institute of Mental Health (NIMH); University of Pennsylvania; University... and other collaboratorsCompletedBehavioral Symptoms | ImplementationUnited States
-
Jonsson Comprehensive Cancer CenterAmerican Cancer Society, Inc.CompletedRectal Cancer | Colon CancerUnited States
-
Louisiana State University Health Sciences Center...University of California, Los Angeles; University of Southern California; National...CompletedDepression | Quality of Life | Anxiety | Social Stress | DisasterUnited States
-
Florida State UniversityUniversity of Pennsylvania; Nova Southeastern UniversityNot yet recruiting
-
University Hospital, Strasbourg, FranceUnknown
-
University of PennsylvaniaCompletedAtherosclerotic Cardiovascular DiseaseUnited States
-
Tennessee State UniversityNational Institutes of Health (NIH)Enrolling by invitation